A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) and best way to take (optimal route of administration) JNJ-89402638 and to determine the safety of JNJ-89402638 at the RP2D(s) in participants with metastatic colorectal cancer (mCRC) and metastatic gastric cancer (mGAC) and to determine the safety and tolerability of JNJ-89402638 in combination with bevacizumab or biosimilar with or without chemotherapy in participants with mCRC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci z potwierdzonym rakiem jelita grubego, który nie reaguje na wcześniejsze leczenie.
- •Pacjenci z potwierdzonym rakiem żołądka, który nie reaguje na wcześniejsze leczenie.
- •Choroba musi być widoczna w badaniach obrazowych lub możliwa do oceny.
- •Pacjenci muszą być w dobrym ogólnym stanie zdrowia (według skali ECOG 0-1).
- •Wydolność nerek musi być odpowiednia (GFR >= 30 mL/min).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 6, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (11)
University of Colorado Denver Anschultz Medical Campus
Aurora, United States
Florida Cancer Specialists
Sarasota, United States
Community Health Network
Indianapolis, United States
Start Midwest
Grand Rapids, United States
Swedish Cancer Institute
Seattle, United States
Severance Hospital Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Hosp Univ Vall D Hebron
Barcelona, Spain
Hosp Univ Fund Jimenez Diaz
Madrid, Spain
Hosp. Univ. 12 de Octubre
Madrid, Spain
Hosp Univ Hm Sanchinarro
Madrid, Spain
Trial contact
Study Contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.